BenevolentAI

BenevolentAI
AI-powered drug discovery company
Machine Learning
Drug Discovery
Bioinformatics
Natural Language Processing
Knowledge Graphs
BenevolentAIの求人
求人0件
現在募集中の求人はありません
製品・サービス
BE
BenevolentAI Drug Discovery Platform
Drug Discovery

AI Drug Discovery Platform
AI Platform
KN
Knowledge Graph
Data Intelligence
BE
BenevolentAI Platform
Drug Discovery Platform

Target Identification Services
Drug Discovery Services

Drug Repurposing Solutions
Drug Discovery Services

Pharmaceutical Partnerships
Partnership Services

Biomedical Knowledge Graph
Data Platform
TA
Target Identification
Drug Discovery Service

Scientific Literature Analysis
AI Platform
DR
Drug Repurposing Platform
Drug Discovery
LI
Literature Mining Tools
AI Tools
CL
Clinical Trial Optimization
Clinical Research Service
PA
Partnership Programs
Partnerships
DR
Drug Repurposing
Drug Discovery Service

Compound Prediction Models
AI Platform
BI
Biomarker Discovery
Diagnostics
CO
Compound Design
Drug Discovery Service
経営陣
JS
Joanna Shields
CEO
類似企業

Schrodinger
Specializes in developing computational tools and software for drug discovery and materials science.
New York City, New York
501-1,000名
Public
企業価値 $2.1B
11件の求人

Xaira
AI for drug discovery
San Francisco, CA
51-200名
Private
企業価値 2.1B

Eli Lilly
Develops medicines for serious and chronic diseases
Indianapolis, Marion County
10,001+名
Public
企業価値 $588B
359件の求人
Regeneron
Focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations int...
Eastview, Mount Pleasant
10,001+名
Public
企業価値 $76B
453件の求人

Isomorphic Labs
Alphabet AI drug discovery lab (DeepMind spinoff)
London, Greater London
51-200名
Private
15件の求人
最新情報
All
X
News
HN
YouTube
BenevolentAI And AstraZeneca Collaborate On New Lupus Target Sam O'reilly (hNAB4pTc9p) - Mshale
Mshale
News
·
3週間前
BENEVOLENTAI (BAIVF) holdings - Yahoo Finance Australia
Yahoo Finance Australia
News
·
1ヶ月前
BenevolentAI And AstraZeneca Collaborate On New Lupus Target Sam O'reilly (hNAB4pTc9p) - Mshale
Mshale
News
·
1ヶ月前
Amyotrophic Lateral Sclerosis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - Barchart.com
Barchart.com
News
·
2ヶ月前
Amyotrophic Lateral Sclerosis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - Barchart.com
Barchart.com
News
·
2ヶ月前
もっと見る (残り4件)
閲覧数
5
応募クリック
0
模擬応募
0
スクラップ
0
レビュー
4.1
10件のレビュー
ワークライフバランス
3.2
報酬
4.0
企業文化
4.3
キャリア
3.5
経営陣
4.2
75%
知人への推奨率
良い点
Supportive team and colleagues
Innovative and cutting-edge projects
Good work-life balance and flexibility
改善点
High pressure and stress
Heavy workload and overtime
Limited career advancement
連絡先・所在地